Stock Track | Moderna Soars 5.03% Intraday on EU Vaccine Approval and Analyst Upgrades

Stock Track

Feb 17

Moderna, Inc. (MRNA) stock surged 5.03% during intraday trading on Tuesday, marking a significant upward movement for the biotechnology company.

The price increase follows Moderna's announcement that it has received marketing authorization from the European Commission for its new COVID-19 vaccine, mNEXSPIKE. The authorization is valid across all 27 European Union member states as well as Iceland, Liechtenstein, and Norway, expanding Moderna's market reach for its third authorized vaccine in the region.

Additionally, the stock movement was supported by positive analyst actions, including Bernstein raising its price target on Moderna to $45 from $35 and Evercore ISI increasing its target to $35 from $28, both reflecting growing confidence in the company's prospects following the regulatory milestone.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1192667144"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1192667144\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1192667144?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-17 22:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192667144","market":"us","top_or_hot":-1,"title":"Stock Track | Moderna Soars 5.03% Intraday on EU Vaccine Approval and Analyst Upgrades","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) stock surged 5.03% during intraday trading on Tuesday, marking a significant upward movement for the biotechnology company.</p><p>The price increase follows Moderna's announcement that it has received marketing authorization from the European Commission for its new COVID-19 vaccine, mNEXSPIKE. The authorization is valid across all 27 European Union member states as well as Iceland, Liechtenstein, and Norway, expanding Moderna's market reach for its third authorized vaccine in the region.</p><p>Additionally, the stock movement was supported by positive analyst actions, including Bernstein raising its price target on Moderna to $45 from $35 and Evercore ISI increasing its target to $35 from $28, both reflecting growing confidence in the company's prospects following the regulatory milestone.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Soars 5.03% Intraday on EU Vaccine Approval and Analyst Upgrades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Soars 5.03% Intraday on EU Vaccine Approval and Analyst Upgrades\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-17 22:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (MRNA) stock surged 5.03% during intraday trading on Tuesday, marking a significant upward movement for the biotechnology company.</p><p>The price increase follows Moderna's announcement that it has received marketing authorization from the European Commission for its new COVID-19 vaccine, mNEXSPIKE. The authorization is valid across all 27 European Union member states as well as Iceland, Liechtenstein, and Norway, expanding Moderna's market reach for its third authorized vaccine in the region.</p><p>Additionally, the stock movement was supported by positive analyst actions, including Bernstein raising its price target on Moderna to $45 from $35 and Evercore ISI increasing its target to $35 from $28, both reflecting growing confidence in the company's prospects following the regulatory milestone.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1192667144","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192667144","pubTimestamp":1771339842,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc. (MRNA) stock surged 5.03% during intraday trading on Tuesday, marking a significant upward movement for the biotechnology company.The price increase follows Moderna's announcement that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"个股追踪|欧盟疫苗获批及分析师上调Moderna盘中大涨5.03%","themeId":"7e06c0190da3dbdabd8f9af0f87f85ff","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) stock surged 5.03% during intraday trading on Tuesday, marking a significant upward movement for the biotechnology company.The price increase follows Moderna's announcement that it has received marketing authorization from the European Commission for its new COVID-19 vaccine, mNEXSPIKE. The authorization is valid across all 27 European Union member states as well as Iceland, Liechtenstein, and Norway, expanding Moderna's market reach for its third authorized vaccine in the region.Additionally, the stock movement was supported by positive analyst actions, including Bernstein raising its price target on Moderna to $45 from $35 and Evercore ISI increasing its target to $35 from $28, both reflecting growing confidence in the company's prospects following the regulatory milestone.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}